UF News

IAEA Program on Remote & Automated QC in Radiography & Mammography

Dr. Manuel Arreola, vice-chair of Medical Physics, and Zahra Razi, Medical Physics Graduate Program Ph.D. student at the University of Florida, contributed to the publication of the International Atomic Energy Agency’s (IAEA) Program on Remote and Automated QC in Radiography and Mammography.

Rain Neuromorphics Tapes Out Demo Chip for Analog AI

UF startup and UF Innovate | Accelerate graduate Rain Neuromorphics, which incubated at The Hub, has taped out a demonstration chip for its brain-inspired analog architecture that employs a 3D array of randomly-connected memristors to compute neural network training and inference at extremely low power.

Dialectic Therapeutics Announces First-in-Human Dose in Phase 1 Clinical Trial Evaluating DT2216, Its First Generation Antiapoptotic Protein Targeted Degradation (APTaD™) Compound, in Patients With Relapsed or Refractory Malignancies

UF startup Dialectic Therapeutics, Inc., a Texas-based clinical-stage biotechnology company focused on creating innovative new technologies to treat cancer, announced the dosing of the first patient in a first-in-human, dose-escalation Phase 1 trial evaluating DT2216, the first generation compound built using its proprietary and novel Antiapoptotic Protein Targeted Degradation (APTaD™) technology, in patients with relapsed or refractory solid tumor and hematologic malignancies.

Want our news in your inbox every Monday morning? You can!

Subscribe Here